Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murray Baron

Showing results (251-260 of 281) with videos related to

Pageof 29
Sort By:
Arthritis Care & Research|March 18, 2010
Psychological health and well-being in systemic sclerosis: State of the science and consensus research agendaBrett D Thombs, Wim van Lankveld, Marielle Bassel, et al.
Annals of the Rheumatic Diseases|September 14, 2016
The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity indexGabriele Valentini, Michele Iudici, Ulrich A Walker, et al.
Journal of Scleroderma and Related Disorders|March 26, 2019
An Interim Report of the Scleroderma Clinical Trials Consortium Working GroupsMurray Baron, Bashar Kahaleh, Elana J Bernstein, et al.
Frontiers in Immunology|September 22, 2025
Severe fatigue is associated with diminished lung function and elevated Galectin-9 levels in early systemic sclerosisCharmaine van Eeden, Maryam Rezaeifar, Muhammad Elezzabi, et al.
Journal of Scleroderma and Related Disorders|May 19, 2025
Recommendations for the local management of digital ulcers in systemic sclerosis: A report from the World Scleroderma Foundation (WSF) 'Ad hoc committee'Corrado Campochiaro, Yossra A Suliman, Dilia Giuggioli, et al.
Rheumatology (Oxford, England)|February 6, 2009
Evaluation of the clinimetric properties of the Early Inflammatory Arthritis--self-administered comorbidity questionnaireMurray Baron, Orit Schieir, Marie Hudson, et al.
Nature Medicine|December 8, 2017
Corrigendum: ADAM10-mediated ephrin-B2 shedding promotes myofibroblast activation and organ fibrosisDavid Lagares, Parisa Ghassemi-Kakroodi, Caroline Tremblay, et al.
Lancet (London, England)|May 10, 2016
Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trialDinesh Khanna, Christopher P Denton, Angelika Jahreis, et al.
Nature Medicine|October 24, 2017
ADAM10-mediated ephrin-B2 shedding promotes myofibroblast activation and organ fibrosisDavid Lagares, Parisa Ghassemi-Kakroodi, Caroline Tremblay, et al.
Rheumatology (Oxford, England)|September 6, 2016
Calcinosis is associated with digital ischaemia in systemic sclerosis-a longitudinal studyMurray Baron, Janet Pope, David Robinson, et al.
Pageof 29

Showing results (251-260 of 281) with videos related to

Sort By:
Pageof 29
Arthritis Care & Research|March 18, 2010
Psychological health and well-being in systemic sclerosis: State of the science and consensus research agendaBrett D Thombs, Wim van Lankveld, Marielle Bassel, et al.
Annals of the Rheumatic Diseases|September 14, 2016
The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity indexGabriele Valentini, Michele Iudici, Ulrich A Walker, et al.
Journal of Scleroderma and Related Disorders|March 26, 2019
An Interim Report of the Scleroderma Clinical Trials Consortium Working GroupsMurray Baron, Bashar Kahaleh, Elana J Bernstein, et al.
Frontiers in Immunology|September 22, 2025
Severe fatigue is associated with diminished lung function and elevated Galectin-9 levels in early systemic sclerosisCharmaine van Eeden, Maryam Rezaeifar, Muhammad Elezzabi, et al.
Journal of Scleroderma and Related Disorders|May 19, 2025
Recommendations for the local management of digital ulcers in systemic sclerosis: A report from the World Scleroderma Foundation (WSF) 'Ad hoc committee'Corrado Campochiaro, Yossra A Suliman, Dilia Giuggioli, et al.
Rheumatology (Oxford, England)|February 6, 2009
Evaluation of the clinimetric properties of the Early Inflammatory Arthritis--self-administered comorbidity questionnaireMurray Baron, Orit Schieir, Marie Hudson, et al.
Nature Medicine|December 8, 2017
Corrigendum: ADAM10-mediated ephrin-B2 shedding promotes myofibroblast activation and organ fibrosisDavid Lagares, Parisa Ghassemi-Kakroodi, Caroline Tremblay, et al.
Lancet (London, England)|May 10, 2016
Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trialDinesh Khanna, Christopher P Denton, Angelika Jahreis, et al.
Nature Medicine|October 24, 2017
ADAM10-mediated ephrin-B2 shedding promotes myofibroblast activation and organ fibrosisDavid Lagares, Parisa Ghassemi-Kakroodi, Caroline Tremblay, et al.
Rheumatology (Oxford, England)|September 6, 2016
Calcinosis is associated with digital ischaemia in systemic sclerosis-a longitudinal studyMurray Baron, Janet Pope, David Robinson, et al.
Pageof 29